Global Haemodynamic Monitoring Systems Market Report and Forecast 2024-2032

Global Haemodynamic Monitoring Systems Market Size

The global haemodynamic monitoring systems market was valued at USD 1.11 billion in 2023 driven by the rising advancements in haemodynamic monitoring systems and the increasing burden of cardiovascular diseases. The market is further expected to grow at a CAGR of 5.2% in the forecast period of 2024-2032 to reach a value of over USD 1.75 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Haemodynamic Monitoring Systems Market Outlook

• The rising burden of cardiovascular diseases and the growing geriatric population drive the market demand in the forecast period.

• Minimally invasive monitoring systems hold a significant market share owing to the rising advancements in sensor technology and data analytics that have improved the accuracy and reliability of these devices.

• In North America, the market is likely to grow over the forecast period because of rising regulatory approvals for monitoring devices and new product releases.

Global Haemodynamic Monitoring Systems Market Overview

Hemodynamic monitoring systems are devices that allow for the evaluation and optimisation of haemodynamic parameters and oxygen delivery, which aids in the diagnosis and treatment of a variety of cardiopulmonary disorders and improving outcomes in critically ill patients. Haemodynamic monitoring has progressed over time from simple CO tracking to complex sensors that offer data on a variety of factors, such as blood pressure, blood volume, and fluid balance.

The haemodynamic monitoring systems market share is influenced by the increasing cases of critically ill geriatric patients, the rising prevalence of cardiac disorders, and the surging demand for home-based and non-invasive monitoring systems. The advancements in technology due to funding from private players and government bodies and the increasing prevalence of hypertension are also propelling the market demand. As haemodynamic monitoring systems are primarily used to assess the cardiovascular health, longevity, and quality of life of patients undergoing or recuperating from cardiac surgery, the parameters are measured using photo metrics, electrical, pressure transducing equipment and invasive and non-invasive devices. Thus, the rising burden of cardiovascular diseases is poised to impact the market dynamics.

The haemodynamic monitoring systems market value is also being driven by factors, such as technological advancements, increasing research and development (R&D) activities, an influx of venture capital funding, the rising incidences of surgeries, industry-wide awareness initiatives, and the growing government focus on critical care infrastructure and services. Also, the increasing demand for patient monitoring devices in non-hospital settings and emerging economies is likely to provide lucrative growth possibilities for market competitors.

Global Haemodynamic Monitoring Systems Market Growth Drivers

Increasing Prevalence of Cardiovascular Diseases Impacts Market Landscape

Recent data reveals that cardiovascular disease is the leading cause of mortality for men and women worldwide. Around 620 million people in the world are affected by heart and circulatory disease, which translates to roughly 1 in 13 people living with a heart or circulatory condition . The rising burden of cardiovascular diseases is a significant growth driver of the market as these devices help in continuous haemodynamic monitoring, early diagnosis, and effective management of the cardiovascular condition necessary to prevent complications.

Technological Advancements Set to Fuel Haemodynamic Monitoring Systems Market Demand

In October 2023 , Chinese medical device company Mindray Bio-Medical Electronics Co., Ltd’s BeneVision N-Series became the first patient monitoring system to integrate the FloTrac sensor (developed by United States-based Edwards Lifesciences) for hemodynamic monitoring, expanding the N-Series capability to monitor patients' hemodynamic condition. This advancement offers a vital tool to healthcare providers for proactively addressing potential declines in a patient's condition and personalizing fluid management strategies. The introduction of such innovative haemodynamic monitoring solutions is expected to bolster the market growth in the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Haemodynamic Monitoring Systems Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Global Haemodynamic Monitoring Systems Segmentation

Market Breakup by System

• Minimally Invasive Monitoring Systems

• Invasive Monitoring System

• Non-Invasive Monitoring Systems

Market Breakup by Application

• Laboratory-Based Monitoring Systems

• Home-Based Monitoring Systems

• Hospital-Based Monitoring Systems

Market Breakup by Product

• Monitors

• Disposables

Market Breakup by End User

• Hospitals

• Clinics and Ambulatory Care Centers

• Home Care Settings

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Haemodynamic Monitoring Systems Market Share

Market Segmentation Based on System is Anticipated to Witness Substantial Growth

By system, the market is segmented into minimally invasive monitoring systems, invasive monitoring systems, and non-invasive monitoring systems. Minimally invasive monitoring systems hold a significant market share owing to the rising advancements in sensor technology and data analytics that have improved the accuracy and reliability of these devices. These systems are suitable for a broader patient population as they offer less discomfort and shorter recovery times. Moreover, non-invasive monitoring systems are also poised to witness considerable growth driven by increasing demand for patient-friendly monitoring methods, innovations in non-invasive technology, and the rising preference for outpatient and homecare settings.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Haemodynamic Monitoring Systems Market Analysis by Region

North America holds a significant share of the market, owing to rapid technological advancements in the region. The rising development of technologically equipped hospitals and the increasing number of critically sick patients treated in countries like the United States and Canada are driving the market demand. As the prevalence of diseases, such as cancer, hyperthermia, and other cardiovascular issues is surging, the use of haemodynamic monitoring systems is significantly increasing, which is fuelling the market growth.

The haemodynamic monitoring systems market is likely to grow over the forecast period because of rising regulatory approvals for monitoring devices and new product releases in the region. The growth can also be attributed to the high prevalence of cardiovascular diseases and diabetes and the increasing product launches. The intensifying competition in the region is leading to the development of innovative haemodynamic monitoring systems, which are further projected to boost the market share. Additionally, the Asia Pacific region is expected to witness robust growth owing to the rising governmental focus on quality healthcare, high demand for monitoring devices from India, China and Japan, and high diabetes prevalence.

Leading Players in the Global Haemodynamic Monitoring Systems Market

The key features of the market report comprise patent analysis, and strategic initiatives such as joint ventures along with partnerships and collaborations by the key players. The major companies in the market are as follows:

Getinge AB

This global provider of medical technology solutions has a prominent presence in the market. Its advanced hemodynamic patient monitoring platform, PulsioFlex , features modular expandability and efficient monitoring technologies.

Edwards Lifesciences

Headquartered in California, Edwards Lifesciences is an American medical technology company specialising in haemodynamic monitoring. It boasts a robust portfolio of advanced hemodynamic monitoring solutions comprising a range of sensors, software, cuffs, and catheters.

Koninklijke Philips N.V.

Technology company Koninklijke Philips N.V. is one of the leading market players and significantly contributes to the haemodynamic monitoring systems market growth. One of its key products is the IntelliVue monitoring system which includes advanced haemodynamic monitoring features integrated into comprehensive patient monitoring solutions.

ICU Medical, Inc.

ICU Medical is a medical device company that is known for its innovative Cogent 2-in-1 hemodynamic monitoring system. Cogent 2-in-1 Hemodynamic Monitoring System is designed to accept both minimally invasive and invasive inputs, allowing healthcare providers to use a single monitor regardless of changes in patient conditions and monitoring requirements.

Other key players in the market include LiDCO Limited, Schwarzer Cardiotek GmbH, OSYPKA MEDICAL, Nihon Kohden Corporation, Deltex Medical Limited, and TELEFLEX INC.

Key Highlights of the Report

Key Questions Answered in the Global Haemodynamic Monitoring Systems Market Report

• What was the global haemodynamic monitoring systems market value in 2023?
• What is the global haemodynamic monitoring systems market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What is market segmentation based on the system?
• What is the market breakup based on application?
• Who are the major end users in the market?
• What types of products are present in the market?
• What are the major factors aiding the global haemodynamic monitoring systems market demand? 
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• How does the prevalence and incidence of cardiovascular diseases affect the market landscape?
• What are the major global haemodynamic monitoring systems market trends?
• How does the rise in the geriatric population impact the market size?
• Which system will dominate the market share? 
• Which application area is expected to have a high market value in the coming years?
• Which product type will experience the highest demand in the market segment?
• Which end user is projected to contribute to the highest market growth?
• Who are the key players involved in the haemodynamic monitoring systems market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?